Literature DB >> 26064468

Selective pulmonary vasodilation improves ventriculovascular coupling and gas exchange in a patient with unrepaired single-ventricle physiology.

F Rischard1, R Vanderpool2, I Jenkins3, M Dalabih1, J Colombo4, D Lax4, M Seckeler4.   

Abstract

We describe a 63-year-old patient with unrepaired tricuspid valve atresia and a hypoplastic right ventricle (single-ventricle physiology) who presented with progressive symptomatic hypoxia. Her anatomy resulted in parallel pulmonary and systemic circulations, pulmonary arterial hypertension, and uncoupling of the ventricle/pulmonary artery. Hemodynamic and coupling data were obtained before and after pulmonary vasoactive treatment, first inhaled nitric oxide and later inhaled treprostinil. The coupling ratio (ratio of ventricular to vascular elastance) shunt fractions and dead space ventilation were calculated before and after treatment. Treatment resulted in improvement of the coupling ratio between the ventricle and the vasculature with optimization of stroke work, equalization of pulmonary and systolic flows, a decrease in dead space ventilation from 75% to 55%, and a significant increase in 6-minute walk distance and improved hypoxia. Inhaled treprostinil significantly increased 6-minute walk distance and improved hypoxia. This is the first report to show that pulmonary vasoactive treatment can be used in a patient with unrepaired single-ventricle anatomy and describes the hemodynamic effects of inhaled therapy on ventriculovascular coupling and gas exchange in the pulmonary circulation in this unique physiology.

Entities:  

Keywords:  congenital heart disease; pulmonary hypertension; treatment effect; ventricular/vascular coupling hemodynamics

Year:  2015        PMID: 26064468      PMCID: PMC4449254          DOI: 10.1086/681269

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  11 in total

1.  Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension.

Authors:  E P Chen; H B Bittner; R D Davis; P Van Trigt
Journal:  J Surg Res       Date:  1997-05       Impact factor: 2.192

2.  Inhaled nitric oxide and inhaled prostaglandin E1: effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension.

Authors:  P Krieg; T Wahlers; W Giess; R Rohde; M Hartrumpf; M Bund; A Haverich
Journal:  Eur J Cardiothorac Surg       Date:  1998-11       Impact factor: 4.191

3.  Inhaled nitric oxide is not a negative inotropic agent in a porcine model of pulmonary hypertension.

Authors:  D J Goldstein; D A Dean; A Smerling; M C Oz; D Burkhoff; M L Dickstein
Journal:  J Thorac Cardiovasc Surg       Date:  1997-09       Impact factor: 5.209

Review 4.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

5.  Ventricular interaction with the loading system.

Authors:  K Sunagawa; K Sagawa; W L Maughan
Journal:  Ann Biomed Eng       Date:  1984       Impact factor: 3.934

6.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

7.  Fetal model of single ventricle physiology: hemodynamic effects of oxygen, nitric oxide, carbon dioxide, and hypoxia in the early postnatal period.

Authors:  V M Reddy; J R Liddicoat; J R Fineman; D B McElhinney; J R Klein; F L Hanley
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

8.  The role of physiological deadspace and shunt in the gas exchange of patients with pulmonary hypertension: a study of exercise and prostacyclin infusion.

Authors:  B Otulana; T Higenbottam
Journal:  Eur Respir J       Date:  1988-08       Impact factor: 16.671

9.  Mechanisms of gas exchange abnormality in patients with chronic obliterative pulmonary vascular disease.

Authors:  D R Dantzker; J S Bower
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

10.  Ventricular efficiency predicted by an analytical model.

Authors:  D Burkhoff; K Sagawa
Journal:  Am J Physiol       Date:  1986-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.